Yu C, Li L, Wang S, Xu Y, Wang L, Huang Y, et al. Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: a review. Bioact Mater. 2023;25:430–44.

PubMed  Google Scholar 

Lederman M, et al. Megavoltage advances vs the orthovoltage era. JAMA. 1972;220(3):398–400.

Article  CAS  PubMed  Google Scholar 

Schulz A, Meyer F, Dubrovska A, Borgmann K. Cancer stem cells and radioresistance: DNA repair and beyond. Cancers (Basel). 2019. https://doi.org/10.3390/cancers11060862.

Article  PubMed  PubMed Central  Google Scholar 

Göttgens EL, Ostheimer C, Span PN, Bussink J, Hammond EM, et al. HPV, hypoxia and radiation response in head and neck cancer. Br J Radiol. 2019;92(1093):20180047.

PubMed  Google Scholar 

Good JS, Harrington KJ. The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. Clin Oncol (R Coll Radiol). 2013;25(10):569–77.

Article  CAS  PubMed  Google Scholar 

Kavousi Y, Mohammadi M, Ahmadikamalabadi M, Koosha F, et al. Gold nanoparticles in radiation therapy: an old story yet mesmerizing. Iran J Blood Cancer. 2022;14:140–9.

Article  Google Scholar 

Gong L, Zhang Y, Liu C, Zhang M, Han S. Application of radiosensitizers in cancer radiotherapy. Int J Nanomed. 2021;16:1083–102.

Article  Google Scholar 

Akbari A, Shokati Eshkiki Z, Mayahi S, Amini SM. In-vitro investigation of curcumin coated gold nanoparticles effect on human colorectal adenocarcinoma cell line. Nanomed Res J. 2022;7(1):66–72.

CAS  Google Scholar 

Zhu X, Chen Z, Li X, et al. Diosgenin inhibits the proliferation, migration and invasion of the optic nerve sheath meningioma cells via induction of mitochondrial-mediated apoptosis, autophagy and G0/G1 cell cycle arrest. J BU ON. 2020;25(1):508–13.

Google Scholar 

Raju J, Bird RP, et al. Diosgenin, a naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expression and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007;255(2):194–204.

Article  CAS  PubMed  Google Scholar 

Khathayer F, Ray SK, et al. Diosgenin as a novel alternative therapy for inhibition of growth, invasion, and angiogenesis abilities of different glioblastoma cell lines. Neurochem Res. 2020;45(10):2336–51.

Article  CAS  PubMed  Google Scholar 

Guo W, Chen Y, Gao J, Zhong K, Wei H, Li K, et al. Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells. Cell Cycle. 2019;18(15):1745–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen PS, Shih YW, Huang HC, Cheng HW. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS ONE. 2011;6(5): e20164.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yazdanparast S, Bashash D, Nikkhah Bahrami A, Ghorbani M, Izadirad M, Bakhtiyaridovvombaygi M, et al. Royal jelly induces ROS-mediated apoptosis in acute lymphoblastic leukemia (ALL)-derived Nalm-6 cells: shedding light on novel therapeutic approaches for ALL. Iran J Basic Med Sci. 2024;27(7):801–12.

PubMed  PubMed Central  Google Scholar 

Wang W, Chen Z, Chen X, Ni S, Jia Y, Fan L, et al. DG-8d, a novel diosgenin derivative, decreases the proliferation and induces the apoptosis of A549 cells by inhibiting the PI3k/Akt signaling pathway. Steroids. 2021;174:108898.

Article  CAS  PubMed  Google Scholar 

Mao XM, Zhou P, Li SY, Zhang XY, Shen JX, Chen QX, et al. Diosgenin suppresses cholangiocarcinoma cells via inducing cell cycle arrest and mitochondria-mediated apoptosis. Onco Targets Ther. 2019;12:9093–104.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong J, Li Y, Xiao H, Luo D, Zhang S, Zhu C, et al. Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2. Toxicol Appl Pharmacol. 2019;364:12–21.

Article  CAS  PubMed  Google Scholar 

Liu X, Sun C, Jin X, Li P, Ye F, Zhao T, et al. Genistein enhances the radiosensitivity of breast cancer cells via G₂/M cell cycle arrest and apoptosis. Molecules. 2013;18(11):13200–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fabbrizi MR, Parsons JL. Cell death mechanisms in head and neck cancer cells in response to low and high-LET radiation. Expert Rev Mol Med. 2022;24:e2.

Article  CAS  PubMed Central  Google Scholar 

Ren QL, Wang Q, Zhang XQ, Wang M, Hu H, Tang JJ, et al. Anticancer activity of diosgenin and its molecular mechanism. Chin J Integr Med. 2023;29(8):738–49.

Article  CAS  PubMed  Google Scholar 

Liu Y, Zhou Z, Yan J, Wu X, Xu G, et al. Diosgenin exerts antitumor activity via downregulation of Skp2 in breast cancer cells. Biomed Res Int. 2020;2020:8072639.

Article  PubMed  PubMed Central  Google Scholar 

Sikka S, Shanmugam MK, Siveen KS, Ong TH, Yang MH, Lee JH, et al. Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-κB/STAT3 signaling cascades. Eur J Pharmacol. 2021;906:174274.

Article  CAS  PubMed  Google Scholar 

Kim DS, Jeon BK, Lee YE, Woo WH, Mun YJ, et al. Diosgenin induces apoptosis in HepG2 cells through generation of reactive oxygen species and mitochondrial pathway. Evid Based Complement Altern Med. 2012;2012:981675.

Article  Google Scholar 

Liao J, Jin H, Li S, Xu L, Peng Z, Wei G, et al. Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):454.

Article  PubMed  PubMed Central  Google Scholar 

Salakou S, Kardamakis D, Tsamandas AC, Zolota V, Apostolakis E, Tzelepi V, et al. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo. 2007;21(1):123–32.

CAS  PubMed  Google Scholar 

Leger DY, Liagre B, Corbière C, Cook-Moreau J, Beneytout JL, et al. Diosgenin induces cell cycle arrest and apoptosis in HEL cells with increase in intracellular calcium level, activation of cPLA2 and COX-2 overexpression. Int J Oncol. 2004;25(3):555–62.

CAS  PubMed  Google Scholar 

Li Y, Wang X, Cheng S, Du J, Deng Z, Zhang Y, et al. Diosgenin induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Oncol Rep. 2015;33(2):693–8.

Article  CAS  PubMed  Google Scholar 

Zha L, Qiao T, Yuan S, Lei L. Enhancement of radiosensitivity by CpG-oligodeoxyribonucleotide-7909 in human non-small cell lung cancer A549 cells. Cancer Biother Radiopharm. 2010;25(2):165–70.

CAS  PubMed  Google Scholar 

Wang Y, Yang L, Zhang J, Zhou M, Shen L, Deng W, et al. Radiosensitization by irinotecan is attributed to G2/M phase arrest, followed by enhanced apoptosis, probably through the ATM/Chk/Cdc25C/Cdc2 pathway in p53-mutant colorectal cancer cells. Int J Oncol. 2018;53(4):1667–80.

CAS  PubMed  Google Scholar 

Sur S, Agrawal DK. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies. Mol Cell Biochem. 2016;416(1–2):33–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmadi Kamalabadi M, Ostadebrahimi H, Koosha F, Fatemidokht A, Menbari Oskuie I, Amin F, et al. Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer. Med Oncol. 2024;41(8):205.

Article  CAS  PubMed  Google Scholar 

Bartek J, Lukas J, et al. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell. 2003;3(5):421–9.

Article  CAS  PubMed  Google Scholar 

Sun M, Pan D, Chen Y, Li Y, Gao K, Hu B, et al. Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway. Oncotarget. 2017;8(20):32807–20.

Article  PubMed